DRC Ebola Cases Surge to 782 as Rare Bundibugyo Strain Spreads

782 confirmed cases with 181 deaths; nearly 1 million people displaced by conflict in affected region, hindering outbreak response.
More than four in ten exposed people are not being tracked
Contact tracing coverage has collapsed to 56 percent as conflict displaces nearly a million people in the outbreak zone.

In the eastern reaches of the Democratic Republic of Congo, a rare and vaccine-less strain of Ebola is spreading faster than the systems meant to contain it can respond. Seventy-two new cases emerged in a single day last week, bringing the confirmed toll to 782 infections and 181 deaths — numbers that almost certainly undercount the true scale of suffering. The Bundibugyo strain, conflict-driven displacement of nearly one million people, and collapsing contact tracing have converged into a crisis that tests the outer limits of what public health can accomplish when the ground itself is unstable.

  • The outbreak is accelerating at a pace that outstrips documentation — 72 new cases in 24 hours, and the real caseload is almost certainly larger than laboratories have been able to confirm.
  • The Bundibugyo strain carries a 23% fatality rate and has no approved vaccine or targeted treatment, stripping responders of the medical tools that helped contain previous Ebola crises in the region.
  • Nearly one million people displaced by armed conflict in Ituri province are moving constantly through remote areas, making contact tracing — the backbone of any Ebola response — functionally impossible for more than four in ten exposed individuals.
  • The virus has already crossed into Uganda and spread to North and South Kivu, signaling that containment within Ituri province has not held.
  • Between June 12 and June 14 alone, confirmed cases jumped from 676 to 782 and deaths from 136 to 181 — a trajectory that leaves little margin before the outbreak reaches more densely populated corridors.

The Democratic Republic of Congo is facing an Ebola outbreak that is moving faster than health officials can track it. Last week, 72 new cases were confirmed in a single day, pushing the total to 782 infections and 181 deaths — a fatality rate of roughly 23 percent. The outbreak was not officially confirmed until May 15, weeks after it had already begun circulating, and the true caseload has likely grown beyond what laboratories can document.

What makes containment especially difficult is the virus itself. The Bundibugyo strain, rare in the region, has no approved vaccine or targeted treatment — an absence that stands in stark contrast to the Zaire strain, which has driven most of Congo's previous Ebola crises and at least carries available medical countermeasures. Of the 782 confirmed cases, only 56 people have recovered.

More than 90 percent of cases are concentrated in Ituri province, but the virus is not staying there. It has spread to North and South Kivu and has already crossed into Uganda. Compounding the geographic spread is a human crisis: nearly one million people have been displaced by armed conflict in Ituri, according to the United Nations. These are people in constant motion, crossing remote areas with minimal infrastructure — nearly impossible to locate and monitor.

Contact tracing, the foundational tool of any Ebola response, has buckled under this pressure. Coverage dropped to 56 percent in the most recent reporting period, meaning more than four in ten people exposed to confirmed cases are not being tracked. The gap between what health officials know and what is actually happening is widening by the day. Whether the outbreak can be slowed before it spreads further across borders and into more densely populated areas will depend on what happens in the weeks ahead.

The Democratic Republic of Congo is confronting an Ebola outbreak that is accelerating faster than health officials can track it. In a single day last week, the country's health ministry confirmed 72 new cases, pushing the total to 782 infections and 181 deaths. The real number is almost certainly higher. The outbreak was not officially confirmed until May 15, weeks after it had already begun circulating, and the actual caseload has likely grown beyond what laboratories have been able to document.

What makes this outbreak particularly difficult to contain is the virus itself. The Bundibugyo strain, which is causing this surge, is rare in the region and remains without an approved vaccine or targeted treatment. The Zaire strain, which has driven most of Congo's previous Ebola crises, at least has medical countermeasures available. Bundibugyo offers no such advantage. Among the 782 confirmed cases, 56 people have recovered, but the fatality rate sits at roughly 23 percent—a grim arithmetic that underscores the severity of what is unfolding.

The outbreak is concentrated in Ituri province, where more than 90 percent of all cases have been recorded. But it is not staying contained. Cases have appeared in North Kivu and South Kivu provinces as well, and the virus has already crossed the border into Uganda. The geographic spread is troubling, but the human geography is worse. Nearly one million people have been displaced by armed conflict in Ituri, according to the United Nations Office for the Coordination of Humanitarian Affairs. These are not people sheltering in place where contact tracers can find them. They are moving constantly, fleeing violence, crossing remote areas with minimal infrastructure, making themselves nearly impossible to locate and monitor.

Contact tracing—the foundational tool of any Ebola response—has collapsed under this pressure. Coverage dropped sharply to 56 percent in the most recent reporting period, down from the previous week. This means that more than four in ten people who have been exposed to confirmed cases are not being tracked. The gap between what health officials know and what is actually happening on the ground is widening. As of June 12, the World Health Organization had documented 676 confirmed cases and 136 deaths. Within two days, those numbers had jumped to 782 and 181. The trajectory is steep.

The convergence of factors—a virus without a vaccine, a population in motion due to conflict, infrastructure too fragile to support rapid response, and a disease that spreads through direct contact with blood and body fluids—has created conditions where the outbreak can move faster than the response. Health workers are trying to contain something that is outpacing their ability to see it clearly, let alone stop it. The next weeks will determine whether this outbreak can be slowed before it spreads further across borders and into more densely populated areas.

The outbreak remains concentrated in Ituri province, which accounts for more than 90 percent of all cases, but has spread to North Kivu, South Kivu, and across the border into Uganda.
— DRC Health Ministry
The Hearth Conversation Another angle on the story
Inventor

Why is the Bundibugyo strain such a problem compared to what Congo has dealt with before?

Model

Because there's no vaccine for it. The Zaire strain, which has hit Congo repeatedly, at least has medical tools. With Bundibugyo, doctors can only treat symptoms and hope the patient's immune system wins. That 23 percent fatality rate reflects that helplessness.

Inventor

The contact tracing number—56 percent—that seems like it should be higher by now. What's happening there?

Model

A million people displaced by conflict. You can't trace contacts when people are moving constantly through remote areas, fleeing violence. The system assumes some stability. There is none.

Inventor

So the outbreak is actually bigger than 782 cases?

Model

Almost certainly. It wasn't even confirmed until May 15, weeks after it started. Labs can only test so many samples. The real number is probably climbing faster than anyone can measure.

Inventor

Has it crossed into Uganda?

Model

Yes. Cases are already there. That's the moment when a regional crisis becomes a continental one. Uganda has better infrastructure than eastern Congo, but it also has more population density. If it takes hold there, containment becomes exponentially harder.

Inventor

What would actually slow this down?

Model

A vaccine, or massive resources to find and isolate every case before they infect others. Neither is happening at the scale needed. So you're watching a disease spread into conditions where it thrives.

Contact Us FAQ